Skip to content

Comparative Analysis of Sutures for Fascial Closure in Spinal Surgery

Prospective Analysis of STRATAFIX Symmetric PDS Plus Suture for Fascial Closure in Spinal Surgery; Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03533595
Enrollment
20
Registered
2018-05-23
Start date
2018-11-14
Completion date
2023-04-10
Last updated
2023-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fusion of Spine

Brief summary

STRATAFIX Symmetric PDS Plus sutures will reduce the time required for fascial closure following spinal surgery. A pilot study will aide in the design of a larger randomized controlled trial to compare suture closure time of the STRATAFIX Symmetric PDS Plus sutures versus traditional Vicryl sutures.

Detailed description

Effective and secure suture is integral in spinal surgery, creating a strong barrier for tissue repair and a seal which prevents infection of the surgical site. The goal of any suture is to close the wound while minimizing risks of complications such as wound dehiscence and surgical site infection . A new type of suture, barbed suture, uses integrated barbs to secure the suture to the tissue without requiring knots for fixation. The result is a suture that evenly distributes tension along the length of the incision, while requiring less time to close . Additionally, STRATAFIX sutures offer a Plus antibacterial option for their knotless sutures, which further increases the safety and efficacy of this product. Barbed suture technologies have been utilized in a variety of specialties, but neurosurgery remains unstudied in this respect. The primary aim of this study is to assess the time to closure using STRATAFIX technology. Decreased time to closure directly translates into decreased operating room time, and thus increased savings, especially for high-volume institutions. The secondary aim of this study is to determine the risk for surgical complications using STRATAFIX. Previous studies in other specialties have shown no significant difference in rate of adverse consequences when utilizing barbed sutures. To assess this aim, patients will be evaluated for wound dehiscence, SSI, deep infection, and 30-day rate of readmission for wound infection.

Interventions

DEVICEBarbed

Barbed Suture

Sponsors

Ethicon, Inc.
CollaboratorINDUSTRY
Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18 to 75 years old 2. Patients undergoing thoracolumbar fusion of at least 3 vertebral levels. 3. Patient able to sign informed consent.

Exclusion criteria

1. Current infection (osteomyelitis), diabetes, severely malnourished or other co-morbidities that the investigator believes does not make the patient a good candidate for surgery. 2. Patients with incidental durotomy

Design outcomes

Primary

MeasureTime frameDescription
Reduced operating timesPatient followed for 6 months from surgerySTRATAFIX Symmetric PDS Plus sutures will reduce the time required for fascial closure following spinal surgery. A pilot study will aide in the design of a larger randomized controlled trial to compare suture closure time of the STRATAFIX Symmetric PDS Plus sutures versus traditional Vicryl sutures.

Secondary

MeasureTime frameDescription
Safety evaluation of wound dehiscencePatient followed for 6 months from surgerySubject's surgical site wound will be monitored during the protocol defined time points.
Safety evaluation of surgical site infection (SSI) ratePatient followed for 6 months from surgerySubject's surgical site will be monitored and assessed for infection during the protocol defined time points.
Safety evaluation of 30 days readmission ratesPatient followed for 30 days from surgerySubject will be monitored for 30 days post surgery for AE's and SAE's which result in readmission to the hospital.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026